Duffy Sean P. 4

4 · Omada Health, Inc. · Filed Jan 14, 2026

Insider Transaction Report

Form 4

Period: 2026-01-12

Omada Health, Inc.OMDA

Duffy Sean P.

DirectorChief Executive Officer

Transactions

Exercise/Conversion
Common Stock
2026-01-12$2.55/sh+230,479$587,721→ 357,123 total
Sale
Common Stock
[F1][F2]
2026-01-12$15.35/sh−139,989$2,148,425→ 217,134 total
Sale
Common Stock
[F1][F3]
2026-01-12$15.99/sh−90,490$1,446,727→ 126,644 total
Exercise/Conversion
Common Stock
2026-01-13$2.55/sh+40,796$104,030→ 167,440 total
Sale
Common Stock
[F1][F4]
2026-01-13$15.95/sh−40,796$650,774→ 126,644 total
Exercise/Conversion
Stock Option (Right to Buy)
[F6]
2026-01-12−230,479→ 40,796 total
Exercise: $2.55Exp: 2026-01-27→ Common Stock (230,479 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
[F6]
2026-01-13−40,796→ 0 total
Exercise: $2.55Exp: 2026-01-27→ Common Stock (40,796 underlying)

Holdings

Common Stock
[F5]
(indirect: See footnote)
861,109

Footnotes (6)

[F1]Represents shares underlying non-qualified stock options set to expire imminently on January 27, 2026.
[F2]This transaction was executed in multiple trades at prices ranging from $14.85 to $15.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F3]This transaction was executed in multiple trades at prices ranging from $15.85 to $16.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F4]This transaction was executed in multiple trades at prices ranging from $15.61 to $16.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F5]Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
[F6]The option is fully vested and exercisable.

Signature

/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy|2026-01-14

Documents

1 file

4
form4.xmlPrimary